Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
07/2009
07/01/2009EP1250154B1 G-csf conjugates
07/01/2009EP1141273B1 Method for isolating dna from biological materials
07/01/2009EP1124846B1 Nucleotide and protein sequences of nogo genes and methods based thereon
07/01/2009EP1111059B1 A novel human lysozyme gene, its encoding polypeptide and the method preparing for them
07/01/2009EP1104310B1 Expression and characterization of hiv-1 envelope protein associated with a broadly reactive neutralizing antibody response
07/01/2009EP1080216B1 Retroviral delivery system
07/01/2009EP1025243B1 TRANSCRIPTIONALLY-ACTIVATED AAV INVERTED TERMINAL REPEATS (ITRs) FOR USE WITH RECOMBINANT AAV VECTORS
07/01/2009EP0978563B1 Delta 9-desaturase gene
07/01/2009EP0915973B1 Gene involved in cadasil, method of diagnosis and therapeutic application
07/01/2009EP0871748B1 Delivery of biologically active polypeptides
07/01/2009EP0784688B1 Glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them
07/01/2009CN101473037A Plants with modulated expression of NAC transcription factors having enhanced yield-related traits and a method for making the same
07/01/2009CN101473036A Systematic evaluation of sequence and activity relationships using site evaluation libraries for engineering multiple properties
07/01/2009CN101473035A Method for reinforcing secretion efficiency of recombination exogenous protein in sprout fungi expression system
07/01/2009CN101473034A Larval polypeptides having a nuclease activity
07/01/2009CN101473033A Method of transferring substance into cell
07/01/2009CN101472603A Therapeutic intervention in a genetic disease in an individual by modifying expression of an aberrantly expressed gene
07/01/2009CN101469334A Efficient expression vector for human beta-alexi-2-plant
07/01/2009CN101469333A Preparation of anti-salmonella single chain antibody and transmembrane protein fusion protein
07/01/2009CN101469332A Method for preparing streptavidin labeled phycoerythrobilin combined phycocyanin fluorescent protein
07/01/2009CN101469331A Method for preparing streptavidin labeled phycoerythrobilin combined phycocyanin fluorescent protein
07/01/2009CN101469330A Family shuffling technology system for improvement of multiple genes related to phytase
07/01/2009CN101469329A Compositions and methods for increasing bone mineralization
07/01/2009CN101469328A Preparation of PIL-10 gene adjuvant used for pig vaccine
07/01/2009CN101469327A ITS sequence specific to Klebsiella pneumoniae pneumonia or subsp.ozaenae and use
07/01/2009CN101469326A Nucleotide specific to ITS of Balcillus proteus mirabilis and use thereof
07/01/2009CN100507001C Cell isolation method
07/01/2009CN100506999C Optimized expression of HPV 31 L1 in yeast
07/01/2009CN100506992C Recombinant endothelial chalone high expression technology in bacillus coli
07/01/2009CN100506991C Bioconversion of a fermentable carbon source to 1,3-propanediol by a single microorganism
07/01/2009CN100506990C Malic dehydrogenase related to high photosynthetic capacity and resisting reversal of wheat, coded genes and method for breeding plants of resisting reversal
07/01/2009CN100506989C Mosaic infections bursal disease virus vaccines
07/01/2009CN100506988C Novel serum type streptococcus mutans and utilization of the same
07/01/2009CN100506987C Quantitative PCR detection method for plant of specified genus in food or food raw material
07/01/2009CN100506986C Nucleic acid encoding GAI gene of arabidopsis thaliana
07/01/2009CN100506981C Protein hydrolysates enriched in peptides having a carboxy terminal proline residue
07/01/2009CN100506963C Bleaching compositions containing multiply-substituted protease variants
07/01/2009CN100506845C IFNAR2 mutants, their production and use
07/01/2009CN100506844C Novel peptides
07/01/2009CN100506841C Method and carrier complexes for delivering molecules to cells
07/01/2009CN100506284C Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapy
07/01/2009CN100506277C Combinations of antibodies selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and other therapeutic agents
06/2009
06/30/2009US7554020 Inbred maize line PHDRW
06/30/2009US7554018 GATA transcription factor gene required for sugar sensing; increased expression of these genes can produce plants with improved nitrogen utilization, carbon utilization, seed yield or chlorophyll levels; lower fertilizer use; agronomics
06/30/2009US7554017 Soybean cultivar S06-CL959411
06/30/2009US7554016 Soybean variety D4923560
06/30/2009US7554015 Soybean variety D4483789
06/30/2009US7554014 Soybean variety 0437973
06/30/2009US7554013 Soybean variety 4201823
06/30/2009US7554012 Acyltransferases for improving glyphosate and n-acetyl-amino-methyl phosphonate(ampa) resistance
06/30/2009US7554009 Generation of plants with altered oil content
06/30/2009US7554008 Having higher activity for omega-3 fatty acids than omega-6 fatty acids, of given sequences; increasing polyunsaturated fatty acid (PUFA) content; vectors; transgenic plants, animals
06/30/2009US7554007 by expressing within the plant an exogenous polynucleotide homologous to SEQ ID NO:13;
06/30/2009US7554006 Using plants as bioreactor for production of insulin; treating diabetes
06/30/2009US7554005 Expression vector comprising regulatory sequences for use in propagation of disease and insect resistant plants; biological pest control and tissue egineering
06/30/2009US7554004 Allelic series of genomic modifications in cells
06/30/2009US7554003 transgenic Drosophila whose genome is homozygous for the loechrig (loe) allele and for the Drosophila beta-amyloid precursor-like deletion allele; enhanced vacuolization, sterility in female Drosophila, neurodegeneration, accumulation of fatty acids in the brain; reduction of cholesterol ester; Alzheimer
06/30/2009US7553959 comprises cyanine dyes, xanthene dyes, porphyrin dyes, coumarin dyes or composite dyes for use in labeling nucleic acids or proteins in assay, and as diagnostic aid in genomics/proteomics
06/30/2009US7553956 Nucleotide sequence probes for detecting beer-spoilage lactic acid bacteria; food processing and alcoholic beverages
06/30/2009US7553954 Nucleic acid molecules and other molecules associated with plants
06/30/2009US7553952 transgenic plant; canola, oilseed rape, soybean; host cell; seed
06/30/2009US7553951 Soybean isopentenyl transferase genes and methods of use
06/30/2009US7553950 hydrolase enzymes useful for degrading and analyzing polysaccharides such as glycosaminoglycans including chondroitin sulfate, dermatan sulfate, unsulfated chondroitin and hyaluronan; promotere of nerve regeneration, stroke recovery, treating spinal cord injury,epithelial disease, infections and cancers
06/30/2009US7553947 Oligonucleotide sequence comprising two tags (ditag) for use tool in gene discovery and genetic mapping; gene expression analysis; sequencing enhancement; transcription factor binding sites
06/30/2009US7553946 stationary phase-specific promoter activity in gram positive bacteria; isolated DNA; expression vector; host cell; kits; culturing
06/30/2009US7553944 A nucleotide sequence along with the deduced amino acid sequences of the complete genomic sequence of a novel human coronavirus (CoV-HKU1) of the order Nidovirales; single-stranded RNA virus of positive polarity; immunogenic/vaccine preparations using recombinant and chimeric forms; vectors; cells
06/30/2009US7553943 Hairpin polynucleotide having a loop and a stem region, characterized by a sulfur-based nucleophile attached to an internal nucleotide in the hairpin through a linker to enable binding to a solid support.
06/30/2009US7553941 Long-acting polypeptides and methods of producing same
06/30/2009US7553940 comprising at least two carboxy-terminal peptides (CTP) of chorionic gonadotrophin attached to an EPO (erythropoietin) peptide ; improving a biological half life of an hGH polypeptide
06/30/2009US7553939 Genes that encode cell surface molecules with conserved IgV and mucin domains; diagnosis or staging of cancer; treatment of an immunological disorder; detecting a predisposition to asthma
06/30/2009US7553935 Modified vitamin K-dependent polypeptides
06/30/2009US7553934 Enhanced membrane binding affinity; blood coagulation
06/30/2009US7553933 Human p51 genes and gene products thereof
06/30/2009US7553931 Convertase for use in identifying modulator for treatment and prevention of arthritis, kidney, inflammatory, heart and nervous system disorders
06/30/2009US7553929 Administering nuclear factor kappa beta (nf-kb)peptide nuclear localization sequence to inhibit import of stress-responsive transcription factor; septic shock, skin disorders, autoimmune diseases
06/30/2009US7553927 Which direct localization of polynucleotides; nucleic acid of given sequence that hybridizes with probe; modifies photosynthesis and synthesis of fatty acids, amino acids, oils, carotenoids and starch
06/30/2009US7553830 Compositions for the delivery of negatively charged molecules
06/30/2009US7553822 Compositions and methods for inhibiting translation of a Mect1-MAML2 chimeric gene
06/30/2009US7553668 transgenic plant; host cell; isolated nucleic acid molecule; nucleic acid sequences encoding the coat protein ; DNA expression vector; disease resistance
06/30/2009US7553667 one or more nucleotide sequences of interest in transgenic plants; fusion proteins comprising a DNA binding domain fused to a recruitment factor that is capable of recruiting chromatin remodelling proteins such as HDAC and HAT, to specific DNA sites to regulate expression of a gene of interest
06/30/2009US7553666 Preparation of vaccine master cell lines using recombinant plant suspension cultures
06/30/2009US7553658 Use of certain polymers in a two-phase system for the purification of plasmid DNA from a cell lysate
06/30/2009US7553656 Biologically pure bacterial cultures; alginate is produced in large amounts and with a certain determined content of mannuronate and guluronate residues; high yielding
06/30/2009US7553655 Transgenic cells for use as bioreactors in expression of amidated peptides
06/30/2009US7553652 Polypeptide having amidohydrolase activity capable of hydrolysing 3,3,3-trifluoro-2-hydroxy-2-methyl propionamide in form of the racemate or of an optically active isomer; obtainable from Klebsiella oxytoca, Pseudomonas, Rhodococcus opacus, Arthrobacter ramosus, Bacillus
06/30/2009US7553650 Polynucleotide encoding a mutant transglutaminase
06/30/2009US7553649 Method for producing glucose dehydrogenase from Aspergillus oryzae
06/30/2009US7553648 Cytochrome P450 monooxygenases consisting of thermophilic bacteria
06/30/2009US7553644 Detection and treatment of polycystic kidney disease
06/30/2009US7553643 Comprises modified base such as 6-amino-3-prop-1-ynyl-5-hvdropyrazolo[3,4-d]pyrimidine-4-one
06/30/2009US7553640 Proteolytic polypeptide which generates glycoside for use in prevention and treatment of rheumatic, autoimmune and thrombotic disorders
06/30/2009US7553639 Alpha-synuclein kinase
06/30/2009US7553637 Using expression vector comprising nucleotide sequences coding membrane insertion protein as tool in improving exogenous gene expression in host cells
06/30/2009US7553636 Plasmid comprising nucleotide sequences coding poly- gamma -glutamate synthetase for use in developing vaccine for prevention and treatment of bacillus infection
06/30/2009US7553635 Nucleic acids which code for protein from Acremonium chrysogenum; host cells
06/30/2009US7553634 Lysis, fermentation, diafiltration
06/30/2009US7553630 Detecting metalloproteinase inhibitor in sample of tissue, serum, urine, tumor; detectable label is a monoclonal antibody; radioimmunoassay, enzyme linked immunoassay
06/30/2009US7553628 Production of polyunsaturated fatty acids in oleaginous yeasts
06/30/2009US7553627 Detecting cytosine methylation and methylated cytosine/guanine aggregations; incubate genomic nucleotide sequences adjusting agent, amplify nucleotide sequences, detecting the methylated nucleotide sequences
06/30/2009US7553623 Using E6 viral transcript expression as diagnostic indicator in detection and classification of cervical cancers